Published in
Canadian Diabetes Association, Canadian Journal of Diabetes, 2(42), p. 118-123, 2018
DOI: 10.1016/j.jcjd.2017.11.006
Links
Tools
Angiotensin-Converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers for the Treatment of Hypertension in Adults With Type 2 Diabetes: Why We Favour Angiotensin Receptor Blockers
Journal article published in 2018 by
Thomas A. Mavrakanas 
,
Mark L. Lipman
,
Mark L. Lipman
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 